
About
Aoscang Biopharma (Nantong) Co., Ltd. was founded in 2011, is headquartered in Nantong, Jiangsu, and provides early-stage R&D, cell culture media, and biopharmaceutical contract development and manufacturing services. The company has business and manufacturing operations in Jiangsu and Shanghai in China, Gansu, as well as South Korea and the United States, providing integrated solutions for biopharmaceutical R&D and commercial manufacturing customers.
Services
AI prediction and development platform
Provides AI prediction and development support for multiple molecules, covering capabilities related to high-expression cell line development.
Antibody discovery and engineering modification platform
Provides services related to antibody discovery, optimization, and engineering modification.
Novel linker-toxin and conjugation platform
Provides development services related to linker and toxin screening and conjugation.
Pharmacology, efficacy, and pharmacokinetics evaluation platform
Provides pharmacology, efficacy, and pharmacokinetics evaluation services.
Druggability evaluation platform
Provides molecular druggability evaluation services.
Early-stage sample preparation and cell line construction platform
Provides early-stage R&D sample preparation and cell line construction services.
Structural characterization and novel formulation development platform
Provides structure-function characterization and novel formulation development services.
Innovative complex molecule design and development platform
Provides design and development services for complex molecules.
11 more services
- Commercial culture media
- Culture media formulation contract manufacturing
- Recombinant protein drug production
- Antibody production
- ADC production
- Upstream production
- Downstream purification
- Formulation production
- Process development
- Analysis and formulation
- Culture media development
Capabilities
- Assays and studies
- ADCs
- Target design
- Molecule optimization
- Molecule evaluation
- Antibody discovery
- Engineering modification
6 more
- Druggability evaluation
- Pharmacology and efficacy evaluation
- Pharmacokinetics evaluation
- Structural characterization
- Physicochemical and biochemical characterization
- Analytical testing
- Scale and capacity
- CDMO base of over 40,000 square meters
- Nantong macromolecule drug industrialization base: 5 traditional drug substance production lines
- 1 perfusion process production line
- Vial liquid injection/lyophilized formulation production line, 100,000 bottles per batch
- Pre-filled syringe formulation production line, 64,000 syringes per batch
- Shanghai ADC production center, ADC formulation capacity of 120,000 bottles per batch
7 more
- Gansu Lanzhou base with a total area of 9,908 square meters
- Jiangsu Nantong culture media industrialization base, 6 tons of dry powder per batch
- South Korea Busan culture media base with a total area of 16,827 square meters
- 5000L bioreactor annual demand
- 年产能超千万升
- 100kg, 200kg, 400kg-grade production lines
- 50kg, 850kg, 6,000kg-grade production lines
- Therapeutic areas
- Biopharmaceuticals
- Antibody drugs
- Antibody-drug conjugates (ADC)
- Recombinant proteins
- Human and veterinary vaccines
- Cell therapy
Instruments and platforms
- 200L single-use bioreactor
- 500L single-use bioreactor
- 2000L single-use bioreactor
- Isolator filling line
- Traditional conjugation system
- Enzymatic conjugation system
3 more
- Single-use conjugation technology
- Fully automatic cone mixer
- Low-temperature pin mill
Modalities and species
- Modalities
- ADC
- Species and models
- 哺乳动物细胞表达系统
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: 培养基生产基地
Company
- Type
- CRDMO
- Founded
- 2011
- Quality
- 中国GMP (Nantong macromolecule drug industrialization base) · FDA (Nantong macromolecule drug industrialization base) · EMA (Nantong macromolecule drug industrialization base) · OEB-5级标准 (Shanghai ADC R&D and GMP production base) · cGMP (Culture media production base)
Locations
- Based in
- Nantong, China
- Sites
- 南通, 中国
- 上海, 中国
- 兰州, 中国
- 釜山, 韩国
- Pleasanton, 美国
- Serves
- China, South Korea, United States, Asia-Pacific region, European and American customers, Global